Magnesium-based resorbable scaffold vs permanent metallic sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction: 3-year results of the MAGSTEMI randomised controlled trial-Reference-Cited by-同舟云学术

Magnesium-based resorbable scaffold vs permanent metallic sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction: 3-year results of the MAGSTEMI randomised controlled trial

Published:2022-08 Issue:5 Volume:18 Page:e389-e396
ISSN:1969-6213
Container-title:EuroIntervention
language:
Short-container-title:

Author:

Ortega-Paz Luis,Brugaletta Salvatore,Gomez-Lara Josep,Alfonso Fernando,Cequier Angel,Romaní Sebastián,Bordes Pascual,Serra Antonio,Iñiguez Andrés,Salinas Pablo,García del Blanco Bruno,Goicolea Javier,Hernández-Antolín Rosana,Cuesta Javier,Gómez-Hospital Joan Antoni,Sabaté Manel

Publisher

Europa Digital & Publishing

Subject

Cardiology and Cardiovascular Medicine

Reference16 articles.

1. 10-Year Follow-Up of Patients With Everolimus-Eluting Versus Bare-Metal Stents After ST-Segment Elevation Myocardial Infarction

2. Magnesium-Based Resorbable Scaffold Versus Permanent Metallic Sirolimus-Eluting Stent in Patients With ST-Segment Elevation Myocardial Infarction

3. Bioresorbable scaffolds versus permanent sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction: vascular healing outcomes from the MAGSTEMI trial

4. Very-late restenosis of a magnesium-based resorbable scaffold

5. Optimal dual antiplatelet therapy duration for bioresorbable scaffolds: an individual patient data pooled analysis of the ABSORB trials

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sirolimus-eluting iron bioresorbable scaffold versus cobalt-chromium everolimus-eluting stents in patients with coronary artery disease: Rationale and design of the IRONMAN-II trial;American Heart Journal;2024-09

2. Challenges and Advances in Interventional Cardiology for Coronary Artery Disease Management;Medicina;2024-08-15

3. Long-term outcomes following bioresorbable vascular scaffolds;Expert Review of Cardiovascular Therapy;2024-07-30

4. Optimal lesion preparation before implantation of a Magmaris bioresorbable scaffold in patients with coronary artery stenosis: Rationale, design and methodology of the OPTIMIS study;Contemporary Clinical Trials Communications;2024-04

5. Enhancing the corrosion resistance of magnesium alloys with biodegradable poly(trimethylene carbonate) chemical modification coating;Materials Today Advances;2024-03